All Stories

  1. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  2. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
  3. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
  4. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
  5. Burden of disease scenarios for 204 countries
  6. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  7. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  8. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  9. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  10. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  11. Validity and reliability of Arabic version of pediatric migraine disability assessment scale (Child Self-Report versus Parent Proxy-Report): a multi-center study
  12. The significance of miRNA-191-5P and miRNA-24-3P as novel biomarkers for multiple sclerosis: a case–control study
  13. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  14. Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  15. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  16. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  17. Clinical Predictors of Transation to Secondary Progressive Multiple Sclerosis
  18. Neutrophil-to-Lymphocyte Ratio: a Marker of Neuro-inflammation in Multiple Sclerosis Patients: a Meta-analysis and Systematic Review
  19. Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019–2020: randomized controlled clinical trial
  20. Board Walk
  21. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  22. Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  23. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  24. Helicobacter pylori infection in migraine headache: A true association or an innocent bystander?
  25. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  26. Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study
  27. Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study
  28. Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study
  29. The MuSC-19 study: The Egyptian cohort
  30. Mapping Anemia in Women: Global Trends and Inequality
  31. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  32. Behavior and awareness of multiple sclerosis patients during COVID-19 pandemic in a tertiary center in Egypt
  33. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels
  34. Zinc deficiency correlates with severity of diabetic polyneuropathy
  35. Child Mortality Trends and Targets: GBD 2019 Findings
  36. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  37. Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case–Control Study
  38. Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect
  39. lincR-Ccr2-5′AS and THRIL as potential biomarkers of multiple sclerosis
  40. The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt
  41. Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report
  42. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
  43. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019
  44. The potential role of 2D-speckle tracking echocardiography for detecting left ventricular systolic dysfunction in patients with Parkinson’s disease: a case control study
  45. Five insights from the Global Burden of Disease Study 2019
  46. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  47. FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis
  48. Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era
  49. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  50. Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach
  51. Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
  52. Glutamate and Nitric Oxide as biomarkers for disease activity in patients with multiple sclerosis
  53. Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis
  54. Thalamic Involvement and its Impact on Disability and Cognition in Multiple Sclerosis: A Clinical and Diffusion Tensor Imaging Study
  55. Assessment of School-Aged Children of Mothers With Idiopathic Generalized Epilepsy
  56. Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis
  57. Proprioception Errors in Patients with Cervical Spondylosis at Sagittal Plane
  58. Diffusivity Parameters as Markers for NAGM Involvement and Disease Progression in MS Patients: Diffusion Tensor Imaging Study
  59. Testing of Verbal Fluency in Egyptians
  60. Role of concentric needle Single Fiber Electromyography in detection of subclinical motor involvement in carpal tunnel syndrome
  61. Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients
  62. Objective pain assessment by electrical stimulation
  63. Clinical, diffusion tensor imaging, and cognitive biomarkers of seizure control in patients with juvenile myoclonic epilepsy
  64. Verbal fluency tests in Egyptians: Cultural and educational challenges
  65. P295 Effects of functional electric stimulation and task specific training on gait recovery in patients with stroke: Randomized controlled trial
  66. Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
  67. Urinary 6-Sulphatoxymelatonin Levels and Sleep Disorders in Children With Migraine